Annual Operating Profit
-$229.95 M
-$78.20 M-51.53%
December 31, 2023
Summary
- As of February 7, 2025, SNDX annual operating income is -$229.95 million, with the most recent change of -$78.20 million (-51.53%) on December 31, 2023.
- During the last 3 years, SNDX annual operating profit has fallen by -$158.53 million (-221.96%).
- SNDX annual operating profit is now -977.02% below its all-time high of $26.22 million, reached on December 31, 2021.
Performance
SNDX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$89.58 M
-$15.36 M-20.70%
September 30, 2024
Summary
- As of February 7, 2025, SNDX quarterly operating income is -$89.58 million, with the most recent change of -$15.36 million (-20.70%) on September 30, 2024.
- Over the past year, SNDX quarterly operating profit has dropped by -$33.22 million (-58.95%).
- SNDX quarterly operating profit is now -193.55% below its all-time high of $95.75 million, reached on December 31, 2021.
Performance
SNDX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$321.21 M
-$33.22 M-11.54%
September 30, 2024
Summary
- As of February 7, 2025, SNDX TTM operating income is -$321.21 million, with the most recent change of -$33.22 million (-11.54%) on September 30, 2024.
- Over the past year, SNDX TTM operating profit has dropped by -$127.13 million (-65.50%).
- SNDX TTM operating profit is now -1325.06% below its all-time high of $26.22 million, reached on December 31, 2021.
Performance
SNDX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
SNDX Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -51.5% | -59.0% | -65.5% |
| 3 y3 years | -222.0% | -143.0% | -2043.8% |
| 5 y5 years | -203.1% | -143.0% | -2043.8% |
SNDX Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -977.0% | at low | -193.6% | at low | -1325.1% | at low |
| 5 y | 5-year | -977.0% | at low | -193.6% | at low | -1325.1% | at low |
| alltime | all time | -977.0% | at low | -193.6% | at low | -1325.1% | at low |
Syndax Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$89.58 M(+20.7%) | -$321.21 M(+11.5%) |
| Jun 2024 | - | -$74.22 M(-6.7%) | -$287.99 M(+9.3%) |
| Mar 2024 | - | -$79.51 M(+2.1%) | -$263.45 M(+14.6%) |
| Dec 2023 | -$229.95 M(+51.5%) | -$77.91 M(+38.2%) | -$229.95 M(+18.5%) |
| Sep 2023 | - | -$56.35 M(+13.4%) | -$194.08 M(+12.3%) |
| Jun 2023 | - | -$49.68 M(+8.0%) | -$172.87 M(+7.4%) |
| Mar 2023 | - | -$46.02 M(+9.5%) | -$160.91 M(+6.0%) |
| Dec 2022 | -$151.76 M(-678.8%) | -$42.03 M(+19.6%) | -$151.76 M(+986.0%) |
| Sep 2022 | - | -$35.14 M(-6.8%) | -$13.97 M(-1331.2%) |
| Jun 2022 | - | -$37.72 M(+2.3%) | $1.14 M(-93.1%) |
| Mar 2022 | - | -$36.86 M(-138.5%) | $16.52 M(-37.0%) |
| Dec 2021 | $26.22 M(-136.7%) | $95.75 M(-578.0%) | $26.22 M(-129.3%) |
| Sep 2021 | - | -$20.03 M(-10.3%) | -$89.39 M(+0.2%) |
| Jun 2021 | - | -$22.33 M(-17.8%) | -$89.21 M(+6.9%) |
| Mar 2021 | - | -$27.16 M(+36.8%) | -$83.49 M(+16.9%) |
| Dec 2020 | -$71.42 M(+24.1%) | -$19.86 M(+0.0%) | -$71.42 M(+8.6%) |
| Sep 2020 | - | -$19.85 M(+19.5%) | -$65.77 M(+11.4%) |
| Jun 2020 | - | -$16.61 M(+10.0%) | -$59.06 M(+2.1%) |
| Mar 2020 | - | -$15.10 M(+6.3%) | -$57.83 M(+0.5%) |
| Dec 2019 | -$57.54 M(-24.2%) | -$14.21 M(+8.0%) | -$57.54 M(-8.2%) |
| Sep 2019 | - | -$13.15 M(-14.5%) | -$62.67 M(-7.0%) |
| Jun 2019 | - | -$15.37 M(+3.8%) | -$67.36 M(-5.0%) |
| Mar 2019 | - | -$14.81 M(-23.4%) | -$70.94 M(-6.5%) |
| Dec 2018 | -$75.88 M | -$19.33 M(+8.4%) | -$75.88 M(-0.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | -$17.84 M(-5.9%) | -$76.03 M(+3.3%) |
| Jun 2018 | - | -$18.95 M(-4.1%) | -$73.64 M(+7.5%) |
| Mar 2018 | - | -$19.75 M(+1.3%) | -$68.53 M(+10.6%) |
| Dec 2017 | -$61.95 M(+41.6%) | -$19.49 M(+26.2%) | -$61.95 M(+15.6%) |
| Sep 2017 | - | -$15.45 M(+11.6%) | -$53.61 M(+0.4%) |
| Jun 2017 | - | -$13.84 M(+5.0%) | -$53.40 M(+10.8%) |
| Mar 2017 | - | -$13.18 M(+18.3%) | -$48.19 M(+10.1%) |
| Dec 2016 | -$43.77 M(+113.4%) | -$11.14 M(-26.9%) | -$43.77 M(+17.3%) |
| Sep 2016 | - | -$15.24 M(+76.5%) | -$37.30 M(+33.6%) |
| Jun 2016 | - | -$8.63 M(-1.4%) | -$27.92 M(+12.5%) |
| Mar 2016 | - | -$8.75 M(+87.1%) | -$24.83 M(+21.1%) |
| Dec 2015 | -$20.51 M(-3.8%) | -$4.68 M(-20.1%) | -$20.51 M(+7.3%) |
| Sep 2015 | - | -$5.86 M(+5.7%) | -$19.12 M(-8.9%) |
| Jun 2015 | - | -$5.54 M(+25.0%) | -$21.00 M(-3.6%) |
| Mar 2015 | - | -$4.43 M(+34.8%) | -$21.78 M(+2.1%) |
| Dec 2014 | -$21.33 M(+148.9%) | -$3.29 M(-57.5%) | -$21.33 M(+2.0%) |
| Sep 2014 | - | -$7.74 M(+22.3%) | -$20.92 M(+35.2%) |
| Jun 2014 | - | -$6.32 M(+58.8%) | -$15.47 M(+37.6%) |
| Mar 2014 | - | -$3.98 M(+38.3%) | -$11.24 M(+31.2%) |
| Dec 2013 | -$8.57 M(-1.9%) | -$2.88 M(+26.1%) | -$8.57 M(+50.6%) |
| Sep 2013 | - | -$2.28 M(+8.9%) | -$5.69 M(+67.0%) |
| Jun 2013 | - | -$2.10 M(+60.0%) | -$3.41 M(+160.0%) |
| Mar 2013 | - | -$1.31 M | -$1.31 M |
| Dec 2012 | -$8.73 M | - | - |
FAQ
- What is Syndax Pharmaceuticals annual operating income?
- What is the all time high annual operating profit for Syndax Pharmaceuticals?
- What is Syndax Pharmaceuticals annual operating profit year-on-year change?
- What is Syndax Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Syndax Pharmaceuticals?
- What is Syndax Pharmaceuticals quarterly operating profit year-on-year change?
- What is Syndax Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Syndax Pharmaceuticals?
- What is Syndax Pharmaceuticals TTM operating profit year-on-year change?
What is Syndax Pharmaceuticals annual operating income?
The current annual operating profit of SNDX is -$229.95 M
What is the all time high annual operating profit for Syndax Pharmaceuticals?
Syndax Pharmaceuticals all-time high annual operating income is $26.22 M
What is Syndax Pharmaceuticals annual operating profit year-on-year change?
Over the past year, SNDX annual operating income has changed by -$78.20 M (-51.53%)
What is Syndax Pharmaceuticals quarterly operating income?
The current quarterly operating profit of SNDX is -$89.58 M
What is the all time high quarterly operating profit for Syndax Pharmaceuticals?
Syndax Pharmaceuticals all-time high quarterly operating income is $95.75 M
What is Syndax Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, SNDX quarterly operating income has changed by -$33.22 M (-58.95%)
What is Syndax Pharmaceuticals TTM operating income?
The current TTM operating profit of SNDX is -$321.21 M
What is the all time high TTM operating profit for Syndax Pharmaceuticals?
Syndax Pharmaceuticals all-time high TTM operating income is $26.22 M
What is Syndax Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, SNDX TTM operating income has changed by -$127.13 M (-65.50%)